FASEB J 13:10551064 Fernandez-Garca N, Mart MC, Jimenez A, Sewilla F, Enrique Olmos E (2009) Sub-cellular distribution of glutathione in an Arabidopsis mutant ( vtc1 ) deficient in ascorbate
The emergence of a metabolic drug that incidentally reduces addictive behavior underscores something many clinicians have long suspected: addiction is deeply intertwined with the bodys fundamental regulatory systems appetite, satiety, stress, reward, inflammation including behaviors like binge eating that share overlapping neural pathways
publicly available FDA regulatory communications
Andrew Dilley, a Bumpers College graduate student in the agricultural economics and agribusiness department, was the lead author of the study with McFadden as his adviser
However, this needle hasnt been used, so theres no risk of contamination and putting the cap right back on it is a safe way to hold it until youre ready to inject it
Since then, multiple GLP-1 drugs approved for obesity and diabetes treatment have hit the market, with more in development